Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Jan 7;36(3):501–509. doi: 10.1161/ATVBAHA.115.306885

Figure 7.

Figure 7

Percent of maximal human platelet aggregation (mean ± SEM) in response to adenosine diphosphate (ADP) or thrombin receptor-activating peptide (TRAP) as assessed by impedance aggregometry prior to and two hours after the ingestion of 325 mg aspirin in whole blood preincubated with GLS-409, MRS 2179, or cangrelor. No curve could be fitted to the inhibition of TRAP-stimulated platelet aggregation by MRS 2179.